Construction of a dynamic prediction model for diabetic retinopathy risk in adults with adult-onset type 1 diabetes: a real-world longitudinal cohort study
Frontiers in Clinical Diabetes and Healthcare · 28.07.2026 · 7
DOI: 10.3389/fcdhc.2026.1873754 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Clinical Diabetes and Healthcare, online erschienen am 28.07.2026. Verfasst von Di Bao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Management, National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseas…. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
To construct and validate a dynamic prediction model for diabetic retinopathy (DR) risk in adults with adult-onset type 1 diabetes mellitus (T1DM).
Methods
A longitudinal cohort of 572 adult-onset T1DM patients from a tertiary hospital in Tianjin, China (2014–2023) was analyzed. LASSO regression and multivariable Cox regression with time-varying covariates (duration and HbA1c) were used to identify independent predictors of DR and to construct a nomogram. Model performance was assessed using the concordance index (C-index), area under the receiver operating characteristic curve (AUC), Brier score, calibration curves, Hosmer-Lemeshow test, and decision curve analysis (DCA). Internal validation was performed by bootstrap resampling (1000 replicates).
Results
Multivariable Cox regression identified diabetic peripheral vascular disease, diabetic kidney disease, metabolic bone disease, dynamic disease duration, time-varying HbA1c, body mass index (BMI), and gender as independent predictors of DR. The dynamic model had a C-index of 0.704 (corrected: 0.681), with 1-, 2-, and 3-year AUCs of 0.704, 0.713, and 0.732, respectively. Brier scores were all <0.1. Calibration was acceptable at 2 and 3 years; the 1-year calibration slope was elevated (1.895). Hosmer-Lemeshow test P-values were >0.05 at all time points. The dynamic model outperformed a traditional static model in both discrimination and calibration. DCA showed favorable net clinical benefit for 2- and 3-year predictions.
Conclusion
This study demonstrates the feasibility of dynamic DR risk assessment in adult-onset T1DM. The proposed nomogram may serve as an auxiliary tool for predicting 2- to 3-year DR risk, supporting nurses in risk stratification and individualized screening guidance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infection Management, National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Tianjin…
- Tianjin Medical University, Tianjin, China.
- Department of Ophthalmology, National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Tianjin Instit…
- Department of Medical Record, National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Tianjin Insti…
Zitieren
APA
Bao, D., Li, Y., Mu, C., & Xing, Q. (2026). Construction of a dynamic prediction model for diabetic retinopathy risk in adults with adult-onset type 1 diabetes: a real-world longitudinal cohort study. Frontiers in Clinical Diabetes and Healthcare, 7. https://doi.org/10.3389/fcdhc.2026.1873754
Vancouver
Bao D, Li Y, Mu C, Xing Q. Construction of a dynamic prediction model for diabetic retinopathy risk in adults with adult-onset type 1 diabetes: a real-world longitudinal cohort study. Frontiers in Clinical Diabetes and Healthcare. 2026;7. doi:10.3389/fcdhc.2026.1873754
BibTeX
@article{Bao2026,
author = {Bao, Di and Li, Yingying and Mu, Chun and Xing, Qiuling},
title = {Construction of a dynamic prediction model for diabetic retinopathy risk in adults with adult-onset type 1 diabetes: a real-world longitudinal cohort study},
journal = {Frontiers in Clinical Diabetes and Healthcare},
year = {2026},
volume = {7},
doi = {10.3389/fcdhc.2026.1873754}
}
EUVIMED